Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.
Press releases published on September 29, 2025
INVO Fertility to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
SARASOTA, Fla., Sept. 29, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation …
Beneficient Reports Results for Fourth Quarter & Fiscal Year Ended March 31, 2025
Transformative Year Reduced Operating Costs, Launched New Products and Improved Financial Position Beneficient is Positioned to Capitalize on Adjacent Market Growth Opportunities DALLAS, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (“Ben” …
Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones
– Extends cash runway into at least mid-2027 – SOUTH SAN FRANCISCO, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug …
Viomi Celebrates 7th Nasdaq Anniversary with New Brand Campaign and U.S. Launch of AI Alkaline Mineral Water Purifier, MASTER M1
GUANGZHOU, China, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Viomi Technology Co., Ltd. (“Viomi” or the “Company”) (NASDAQ: VIOT), a leading innovator of home water solutions in China, today celebrated the 7th anniversary of its Nasdaq listing by announcing two …
Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs
Clinical data was reported for the first time in patients receiving an 8 mg dose per injection (Cohort 9 of the dose escalation portion of RESOLVE), the highest dose planned in this trial. Patients in Cohort 9 experienced the largest improvements in tissue …
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates
Last patient last visit (LPLV) milestone in AFFIRM-1 Phase 3 trial of BNC-210 in social anxiety disorder (SAD) achieved; topline readout anticipated in early Q4 2025 Cash runway extended through fiscal Q2 2027 BURLINGTON, Mass., Sept. 29, 2025 (GLOBE …
Creative Global Technology Holdings Limited Announces Fiscal 2025 First Half Financial Results
HONG KONG, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Creative Global Technology Holdings Limited (Nasdaq: CGTL) (the “Company”, “we”, “our”, “us” or “CGTL”), a company which recycles consumer electronic devices headquartered in Hong Kong, today announced its …
Concorde International Group Reports 11% Year-over-Year Revenue Growth to $6.0 million for H1 of 2025
Gross profit increased 30% year-over-year to $1.9 million for H1 2025, compared to $1.5 million for the same period last year Gross margin increased 450 basis points to 31.5% for H1 2025, compared to 27.0% for the same period last year SINGAPORE, Sept. 29, …
MAIA Biotechnology Announces $2.25 Million Private Placement
CHICAGO, IL, Sept. 29, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into …
Precision Optics Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Conference Call Scheduled for today, September 29, 2025, at 5:00pm ET Company introduces fiscal year 2026 Revenue and Adjusted EBITDA guidance Company appoints new Chief Operating Officer GARDNER, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Precision Optics …
Rocket Lab and Synspective Strike Another 10-Launch Deal, Boosting Contracted Missions to 21 Electron Launches
LONG BEACH, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced it has secured a second multi-launch contract with …
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
PONTE VEDRA, Fla., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the gaps in anticoagulation therapy, today announced that it will participate …
IDT Corporation Reports Fourth Quarter and Fiscal Year 2025 Results
4Q25 Gross Profit +12% to $114 million; FY 2025 Gross Profit +14% to $446 million 4Q25 Income from Operations +9% to $22 million; Adjusted EBITDA +33% to $33 million FY 2025 Income from Operations +55% to $100 million; Adjusted EBITDA +43% to $129 million, …
Megan Holdings Limited Announces Closing of $5 Million Initial Public Offering
Malaysia, Kuala Lumpur, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Megan Holdings Limited (the “Company” or “Megan”), a Malaysia-based company principally engaged in the development, construction, and maintenance of aquaculture farms and related works, today …
American Rebel Holdings, Inc. (NASDAQ: AREB) and TSR Nitro Celebrate the American Rebel Beer Dodge Hellcat Victory at NHRA Midwest Nationals—Matt Hagan Wins Big in St. Louis
Matt Hagan Powers American Rebel to Victory at NHRA Midwest Nationals—American Rebel Beer Dodge Hellcat Claims First Win of 2025 Nashville, TN, Sept. 29, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) American Rebel Beverages, and …
The Gross Law Firm Notifies Nutex Health Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – NUTX
NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX). Shareholders who purchased shares of NUTX during the class period listed are encouraged to contact the firm …